Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource | 
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | spectinomycin | 2343 | drug-path | 
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | spectinomycin | 2343 | drug-path | 
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | spectinomycin | 2343 | drug-path | 
| Tight junction | R-HSA-2134514 | map04530 | spectinomycin | 2343 | drug-path | 
| Thyroid cancer | R-HSA-9700206 | map05216 | spectinomycin | 2343 | drug-path | 
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | spectinomycin | 2343 | drug-path | 
| Ribosome | R-HSA-5368277 | map03010 | spectinomycin | 2343 | drug-path | 
| Colorectal cancer | R-HSA-4791275 | map05210 | spectinomycin | 2343 | drug-path | 
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | theophylline | 2153 | drug-path | 
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | theophylline | 2153 | drug-path | 
| Tight junction | R-HSA-2134514 | map04530 | theophylline | 2153 | drug-path | 
| Long-term depression | R-HSA-9620244 | map04730 | theophylline | 2153 | drug-path | 
| Complement and coagulation cascades | R-HSA-114591 | map04610 | theophylline | 2153 | drug-path | 
| Wnt signaling pathway | R-HSA-195721 | map04310 | theophylline | 2153 | drug-path | 
| Acute myeloid leukemia | R-HSA-9680350 | map05221 | theophylline | 2153 | drug-path | 
| Colorectal cancer | R-HSA-4791275 | map05210 | theophylline | 2153 | drug-path | 
| Graft-versus-host disease | R-HSA-1643685 | map05332 | etidronic acid | 656575 | drug-path | 
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | etidronic acid | 656575 | drug-path | 
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | etidronic acid | 656575 | drug-path | 
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | etidronic acid | 656575 | drug-path |